Radiofrequency Ablation Combined With S-1 for Pancreatic Cancer With Liver Metastasis
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study aims to explore the efficacy and safety of radiofrequency ablation combined with
S-1 in pancreatic cancer patients with liver metastasis, as well as the correlation of serum
microRNA and patients' prognosis. This protocol will be overseen by the Fudan University
Institutional Review Board which has Federal Wide Assurance through the U.S. Department of
Health & Human Services (Approved: April 25, 2002).